Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Prostaglandin E2 Receptor EP4 Subtype market report explains the definition, types, applications, major countries, and major players of the Prostaglandin E2 Receptor EP4 Subtype market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Eli Lilly and Co
Ono Pharmaceutical Co Ltd
RaQualia Pharma Inc
Eisai Co Ltd
Kaken Pharmaceutical Co Ltd
Rottapharm Biotech Srl
By Type:
E-7046
ER-886046
grapiprant
KAG-308
ONO-4232
Others
By End-User:
Breast Cancer
Allergies
Chronic Pain
Acute Pain
Lung Cancer
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Prostaglandin E2 Receptor EP4 Subtype Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Prostaglandin E2 Receptor EP4 Subtype Outlook to 2028- Original Forecasts
-
2.2 Prostaglandin E2 Receptor EP4 Subtype Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Prostaglandin E2 Receptor EP4 Subtype Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Prostaglandin E2 Receptor EP4 Subtype Market- Recent Developments
-
6.1 Prostaglandin E2 Receptor EP4 Subtype Market News and Developments
-
6.2 Prostaglandin E2 Receptor EP4 Subtype Market Deals Landscape
7 Prostaglandin E2 Receptor EP4 Subtype Raw Materials and Cost Structure Analysis
-
7.1 Prostaglandin E2 Receptor EP4 Subtype Key Raw Materials
-
7.2 Prostaglandin E2 Receptor EP4 Subtype Price Trend of Key Raw Materials
-
7.3 Prostaglandin E2 Receptor EP4 Subtype Key Suppliers of Raw Materials
-
7.4 Prostaglandin E2 Receptor EP4 Subtype Market Concentration Rate of Raw Materials
-
7.5 Prostaglandin E2 Receptor EP4 Subtype Cost Structure Analysis
-
7.5.1 Prostaglandin E2 Receptor EP4 Subtype Raw Materials Analysis
-
7.5.2 Prostaglandin E2 Receptor EP4 Subtype Labor Cost Analysis
-
7.5.3 Prostaglandin E2 Receptor EP4 Subtype Manufacturing Expenses Analysis
8 Global Prostaglandin E2 Receptor EP4 Subtype Import and Export Analysis (Top 10 Countries)
-
8.1 Global Prostaglandin E2 Receptor EP4 Subtype Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Prostaglandin E2 Receptor EP4 Subtype Export by Region (Top 10 Countries) (2017-2028)
9 Global Prostaglandin E2 Receptor EP4 Subtype Market Outlook by Types and Applications to 2022
-
9.1 Global Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global E-7046 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global ER-886046 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global grapiprant Consumption and Growth Rate (2017-2022)
-
9.1.4 Global KAG-308 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global ONO-4232 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Allergies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Chronic Pain Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Acute Pain Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Prostaglandin E2 Receptor EP4 Subtype Market Analysis and Outlook till 2022
-
10.1 Global Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.2.2 Canada Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.2.3 Mexico Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3.2 UK Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3.3 Spain Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3.4 Belgium Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3.5 France Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3.6 Italy Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3.7 Denmark Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3.8 Finland Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3.9 Norway Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3.10 Sweden Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3.11 Poland Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3.12 Russia Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.3.13 Turkey Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.4.2 Japan Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.4.3 India Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.4.4 South Korea Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.4.5 Pakistan Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.4.6 Bangladesh Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.4.7 Indonesia Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.4.8 Thailand Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.4.9 Singapore Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.4.10 Malaysia Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.4.11 Philippines Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.4.12 Vietnam Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.5.2 Colombia Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.5.3 Chile Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.5.4 Argentina Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.5.5 Venezuela Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.5.6 Peru Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.5.7 Puerto Rico Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.5.8 Ecuador Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.6.2 Kuwait Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.6.3 Oman Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.6.4 Qatar Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.6.5 Saudi Arabia Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.6.6 United Arab Emirates Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.7.2 South Africa Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.7.3 Egypt Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.7.4 Algeria Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
-
10.8.2 New Zealand Prostaglandin E2 Receptor EP4 Subtype Consumption (2017-2022)
11 Global Prostaglandin E2 Receptor EP4 Subtype Competitive Analysis
-
11.1 Eli Lilly and Co
-
11.1.1 Eli Lilly and Co Company Details
-
11.1.2 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Main Business and Markets Served
-
11.1.4 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Ono Pharmaceutical Co Ltd
-
11.2.1 Ono Pharmaceutical Co Ltd Company Details
-
11.2.2 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Main Business and Markets Served
-
11.2.4 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 RaQualia Pharma Inc
-
11.3.1 RaQualia Pharma Inc Company Details
-
11.3.2 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Main Business and Markets Served
-
11.3.4 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Eisai Co Ltd
-
11.4.1 Eisai Co Ltd Company Details
-
11.4.2 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Main Business and Markets Served
-
11.4.4 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Kaken Pharmaceutical Co Ltd
-
11.5.1 Kaken Pharmaceutical Co Ltd Company Details
-
11.5.2 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Main Business and Markets Served
-
11.5.4 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Rottapharm Biotech Srl
-
11.6.1 Rottapharm Biotech Srl Company Details
-
11.6.2 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Main Business and Markets Served
-
11.6.4 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
-
11.6.5 Recent Research and Development Strategies
12 Global Prostaglandin E2 Receptor EP4 Subtype Market Outlook by Types and Applications to 2028
-
12.1 Global Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global E-7046 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global ER-886046 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global grapiprant Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global KAG-308 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global ONO-4232 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Allergies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Chronic Pain Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Acute Pain Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Prostaglandin E2 Receptor EP4 Subtype Market Analysis and Outlook to 2028
-
13.1 Global Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.2.2 Canada Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.2.3 Mexico Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3.2 UK Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3.3 Spain Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3.4 Belgium Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3.5 France Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3.6 Italy Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3.7 Denmark Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3.8 Finland Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3.9 Norway Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3.10 Sweden Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3.11 Poland Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3.12 Russia Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.3.13 Turkey Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.4.2 Japan Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.4.3 India Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.4.4 South Korea Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.4.8 Thailand Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.4.9 Singapore Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.4.11 Philippines Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.5.2 Colombia Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.5.3 Chile Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.5.4 Argentina Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.5.6 Peru Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.6.3 Oman Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.6.4 Qatar Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.7.2 South Africa Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.7.3 Egypt Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.7.4 Algeria Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Prostaglandin E2 Receptor EP4 Subtype
-
Figure of Prostaglandin E2 Receptor EP4 Subtype Picture
-
Table Global Prostaglandin E2 Receptor EP4 Subtype Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Prostaglandin E2 Receptor EP4 Subtype Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global E-7046 Consumption and Growth Rate (2017-2022)
-
Figure Global ER-886046 Consumption and Growth Rate (2017-2022)
-
Figure Global grapiprant Consumption and Growth Rate (2017-2022)
-
Figure Global KAG-308 Consumption and Growth Rate (2017-2022)
-
Figure Global ONO-4232 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Allergies Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Pain Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Pain Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Prostaglandin E2 Receptor EP4 Subtype Consumption by Country (2017-2022)
-
Table North America Prostaglandin E2 Receptor EP4 Subtype Consumption by Country (2017-2022)
-
Figure United States Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Canada Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Mexico Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Table Europe Prostaglandin E2 Receptor EP4 Subtype Consumption by Country (2017-2022)
-
Figure Germany Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure UK Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Spain Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Belgium Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure France Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Italy Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Denmark Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Finland Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Norway Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Sweden Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Poland Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Russia Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Turkey Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Table APAC Prostaglandin E2 Receptor EP4 Subtype Consumption by Country (2017-2022)
-
Figure China Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Japan Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure India Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure South Korea Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Thailand Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Singapore Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Philippines Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Table South America Prostaglandin E2 Receptor EP4 Subtype Consumption by Country (2017-2022)
-
Figure Brazil Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Colombia Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Chile Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Argentina Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Peru Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Table GCC Prostaglandin E2 Receptor EP4 Subtype Consumption by Country (2017-2022)
-
Figure Bahrain Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Oman Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Qatar Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Table Africa Prostaglandin E2 Receptor EP4 Subtype Consumption by Country (2017-2022)
-
Figure Nigeria Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure South Africa Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Egypt Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure Algeria Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Table Oceania Prostaglandin E2 Receptor EP4 Subtype Consumption by Country (2017-2022)
-
Figure Australia Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Prostaglandin E2 Receptor EP4 Subtype Consumption and Growth Rate (2017-2022)
-
Table Eli Lilly and Co Company Details
-
Table Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Main Business and Markets Served
-
Table Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
-
Table Ono Pharmaceutical Co Ltd Company Details
-
Table Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Main Business and Markets Served
-
Table Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
-
Table RaQualia Pharma Inc Company Details
-
Table RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Value and Gross Profit (2017-2022)
-
Table RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Main Business and Markets Served
-
Table RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
-
Table Eisai Co Ltd Company Details
-
Table Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Main Business and Markets Served
-
Table Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
-
Table Kaken Pharmaceutical Co Ltd Company Details
-
Table Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Main Business and Markets Served
-
Table Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
-
Table Rottapharm Biotech Srl Company Details
-
Table Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Main Business and Markets Served
-
Table Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
-
Figure Global E-7046 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ER-886046 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global grapiprant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global KAG-308 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ONO-4232 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Allergies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast by Country (2022-2028)
-
Table North America Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast by Country (2022-2028)
-
Figure United States Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast by Country (2022-2028)
-
Figure Germany Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast by Country (2022-2028)
-
Figure China Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast by Country (2022-2028)
-
Figure Brazil Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast by Country (2022-2028)
-
Figure Australia Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast and Growth Rate (2022-2028)
-
